Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conformis, Inc. stock logo
CFMS
Conformis
$2.26
$2.25
$1.05
$7.25
$17.80M1.3999,585 shs7,000 shs
Eargo, Inc. stock logo
EAR
Eargo
$70.50
$52.85
$1.47
$8.48
$1.46B1.523,347 shsN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
$0.94
$0.56
$1.30
$63.04M2.3541,468 shs303,600 shs
Sientra, Inc. stock logo
SIEN
Sientra
$0.43
$0.16
$4.94
$2.08M2.044.15 million shs3.44 million shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conformis, Inc. stock logo
CFMS
Conformis
0.00%0.00%0.00%0.00%+43.95%
Eargo, Inc. stock logo
EAR
Eargo
0.00%0.00%0.00%+2,520.82%+1,240.30%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
0.00%0.00%0.00%+3.97%+62.76%
Sientra, Inc. stock logo
SIEN
Sientra
0.00%0.00%0.00%-69.47%-88.92%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/AN/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
0.6242 of 5 stars
3.50.00.00.00.00.00.6
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Conformis, Inc. stock logo
CFMS
Conformis
2.00
HoldN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
3.00
Buy$3.00∞ Upside
Sientra, Inc. stock logo
SIEN
Sientra
2.00
HoldN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Conformis, Inc. stock logo
CFMS
Conformis
$57.06M0.31N/AN/A$4.07 per share0.56
Eargo, Inc. stock logo
EAR
Eargo
$41.11M35.61N/AN/A$4.87 per share14.48
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
$5.51M0.00N/AN/A$1.10 per share0.00
Sientra, Inc. stock logo
SIEN
Sientra
$90.55M0.00N/AN/A($0.04) per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Conformis, Inc. stock logo
CFMS
Conformis
-$50.47M-$5.61N/AN/AN/A-72.72%-86.46%-47.65%N/A
Eargo, Inc. stock logo
EAR
Eargo
-$157.49M-$7.52N/AN/A-263.14%-135.08%-96.37%N/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
-$19.57M-$0.37N/AN/AN/A-238.35%-29.00%-25.27%N/A
Sientra, Inc. stock logo
SIEN
Sientra
-$73.31M-$5.57N/AN/AN/A-65.93%N/A-40.45%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
N/AN/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Conformis, Inc. stock logo
CFMS
Conformis
0.64
5.07
3.30
Eargo, Inc. stock logo
EAR
Eargo
N/A
3.22
2.97
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
N/A
3.47
2.99
Sientra, Inc. stock logo
SIEN
Sientra
N/A
0.57
0.31

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Conformis, Inc. stock logo
CFMS
Conformis
10.31%
Eargo, Inc. stock logo
EAR
Eargo
80.53%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
3.58%
Sientra, Inc. stock logo
SIEN
Sientra
15.38%

Insider Ownership

CompanyInsider Ownership
Conformis, Inc. stock logo
CFMS
Conformis
3.80%
Eargo, Inc. stock logo
EAR
Eargo
0.81%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
2.10%
Sientra, Inc. stock logo
SIEN
Sientra
1.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Conformis, Inc. stock logo
CFMS
Conformis
2957.88 million7.58 millionNot Optionable
Eargo, Inc. stock logo
EAR
Eargo
24320.76 million20.59 millionNot Optionable
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
5660.03 million58.76 millionOptionable
Sientra, Inc. stock logo
SIEN
Sientra
30411.96 million11.78 millionOptionable

EAR, CFMS, RWLK, and SIEN Headlines

SourceHeadline
California-based manufacturer of breast implants closing Franklin facility as part of bankruptcyCalifornia-based manufacturer of breast implants closing Franklin facility as part of bankruptcy
biztimes.com - April 22 at 2:14 PM
Sientra Inc SIENQSientra Inc SIENQ
morningstar.com - April 22 at 12:31 AM
Nuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis PortfolioNuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis Portfolio
finance.yahoo.com - April 18 at 3:40 PM
Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033
pharmiweb.com - April 13 at 7:57 AM
Breast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.bizBreast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.biz
pharmiweb.com - April 12 at 5:47 AM
Nasdaq (NDAQ) Initiated with a Buy at BarclaysNasdaq (NDAQ) Initiated with a Buy at Barclays
markets.businessinsider.com - April 11 at 7:34 AM
Medical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth RateMedical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth Rate
pharmiweb.com - April 8 at 4:33 PM
Global Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI AnalysisGlobal Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI Analysis
fmiblog.com - April 4 at 6:23 PM
Aesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.usAesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.us
pharmiweb.com - April 4 at 8:22 AM
Sientra Sells Business Parts for $50M+Sientra Sells Business Parts for $50M+
ocbj.com - April 3 at 3:53 PM
Sientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
finanznachrichten.de - April 3 at 10:53 AM
Nuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment BrandNuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment Brand
finance.yahoo.com - April 3 at 10:53 AM
Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
globenewswire.com - April 2 at 6:30 PM
Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%
finance.yahoo.com - March 15 at 4:23 AM
Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032
fmiblog.com - March 14 at 11:23 PM
Firm Retention Summary: SientraFirm Retention Summary: Sientra
wsj.com - March 7 at 3:39 PM
Sientra Declares Bankruptcy, Seeks BuyerSientra Declares Bankruptcy, Seeks Buyer
ocbj.com - February 26 at 7:00 PM
Global Extremity Tissue Expanders Industry Poised for a Meteoric Rise, Anticipating US$ 1,842.6 Million with a Resounding 6.3% CAGR by 2028 | FMIGlobal Extremity Tissue Expanders Industry Poised for a Meteoric Rise, Anticipating US$ 1,842.6 Million with a Resounding 6.3% CAGR by 2028 | FMI
fmiblog.com - February 21 at 3:22 PM
SIEN Mar 2024 2.500 callSIEN Mar 2024 2.500 call
finance.yahoo.com - February 17 at 8:46 AM
Sientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessSientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
finanznachrichten.de - February 15 at 3:24 PM
Plastic surgery company goes bust, files Chapter 11 bankruptcyPlastic surgery company goes bust, files Chapter 11 bankruptcy
msn.com - February 15 at 3:24 PM
Plastic-surgery company goes bust, files Chapter 11 bankruptcyPlastic-surgery company goes bust, files Chapter 11 bankruptcy
msn.com - February 15 at 10:23 AM
Implant Maker Sientra Cleared to Draw Deerfield Bankruptcy LoanImplant Maker Sientra Cleared to Draw Deerfield Bankruptcy Loan
msn.com - February 14 at 6:42 PM
Health Care Limits Losses Amid Defensive Bias -- Health Care RoundupHealth Care Limits Losses Amid Defensive Bias -- Health Care Roundup
marketwatch.com - February 13 at 8:34 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Conformis logo

Conformis

NASDAQ:CFMS
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
Eargo logo

Eargo

NASDAQ:EAR
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
ReWalk Robotics logo

ReWalk Robotics

NASDAQ:RWLK
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
Sientra logo

Sientra

NASDAQ:SIEN
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.